Major financial data for the past five years is posted.

Major Financial Data

(¥ million)

Jun. 2019

Jun. 2020

Jun. 2021

Jun. 2022

Jun. 2023

Sales

57,216

56,546

61,507

77,748

90,101

Operating income excluding

goodwill amortization

15,317

12,595

12,944

16,893

19,934

Operating income margin

excluding goodwill amortization (%)

26.8

22.3

21.0

21.7

22.1

EBITDA

18,778

16,794

17,764

22,712

26,742

Operating income

15,168

12,445

12,795

15,239

18,030

Operating income margin (%)

26.5

22.0

20.8

19.6

20.0

Ordinary income

14,833

12,310

13,196

16,326

17,635

Net income

11,237

9,178

9,984

10,857

13,106

Net assets

65,450

71,975

92,938

121,130

134,300

Total assets

84,358

93,729

115,427

155,127

172,644

Operating cash flow

11,720

11,166

8,920

17,302

19,138

Investment cash flow

-10,849

-10,389

-16,327

-18,703

-15,135

Free cash flow

871

777

-7,407

-1,401

4,003

Financial cash flow

267

-850

10,110

11,368

-2,342

Depreciation

(including goodwill amortization)

3,460

4,198

4,819

6,439

7,513

R&D expenses

6,036

6,579

7,524

8,869

9,723

Employees:

Consolidated (persons)

7,810

8,761

9,409

10,435

10,186

Employees:

Non-consolidated (persons)

755

875

925

1,041

1,016

Number of shares issued

and outstanding (shares)

260,268,000

260,561,600

265,972,800

271,633,600

271,633,600

Net income per share (¥)

(after adjustment)

43.29

35.25

38.25

40.01

48.25

Net assets per share (¥)

(after adjustment)

251.37

276.13

349.18

439.80

487.12

ROE (Return On Equity) (%)

18.9

13.4

12.1

10.2

10.4

ROIC (Return On Invested Capital) (%)

20.0

13.5

11.7

10.9

10.7

Dividend (¥)

(after adjustment)

10.81

8.81

11.26

11.99

14.48

Consolidated dividend payout ratio (%)

25.0

25.0

30.0

30.0

30.0

Sales by Segment

(¥ million)

Jun. 2019

Jun. 2020

Jun. 2021

Jun. 2022

Jun. 2023

Sales

57,216

56,546

61,507

77,748

90,101

Medical business

48,216

47,855

53,068

68,345

78,552

Device business

9,000

8,690

8,438

9,403

11,549

Cash Flow

(¥ million)

Jun. 2019

Jun. 2020

Jun. 2021

Jun. 2022

Jun. 2023

Operating cash flow

11,720

11,166

8,920

17,302

19,138

Investment cash flow

-10,849

-10,389

-16,327

-18,703

-15,135

Free cash flow

871

777

-7,407

-1,401

4,003

Financial cash flow

267

-850

10,110

11,369

-2,342

Depreciation / R&D Expenses

(¥ million)

Jun. 2019

Jun. 2020

Jun. 2021

Jun. 2022

Jun. 2023

Depreciation

3,460

4,198

4,819

6,439

7,513

R&D Expenses

6,036

6,579

7,524

8,869

9,723

ROE / ROIC

(%)

Jun. 2019

Jun. 2020

Jun. 2021

Jun. 2022

Jun. 2023

ROE (Return On Equity)

18.9

13.4

12.1

10.2

10.4

ROIC (Return On Invested Capital)

20.0

13.5

11.7

10.9

10.7